|Day Low/High||61.21 / 63.24|
|52 Wk Low/High||49.03 / 86.31|
For the week of July 4, investors await earnings from Walgreens Boots Alliance, the FOMC minutes and the June jobs report.
TheStreet's Action Alerts PLUS Portfolio Manager Jim Cramer is keeping an eye on earnings from Walgreens Boots Alliance and PepsiCo, released next week.
The federal government has turned violently against these deals.
There are some good plays out there, but no one seems to want the ball in this gameless market.
Without it, any rally would just be a short-covering bump.
When a stock like WBA isn't trading at a discount, try put options.
The troubled Canadian drugmaker is under increased pressure to sell assets, and quickly.
Sad weekend. Sad day. The big business news item -- Microsoft (MSFT) acquiring LinkedIn (LNKD), but I don't view this as a meaningful positive. I added to my Nasdaq short today at attractive prices. "Trade of the Week" -- long Twitter (TWTR). Odd...
Papa is set to meet with Walgreens management in hopes of ironing out "speed bumps."
Walgreens formally ended its relationship with Theranos.
Walgreens and Theranos split as Apple focuses on Siri and investors wait for the Fed decision.
A Clinton presidency will ensure upending support for ObamaCare, while a Trump presidency won't be able to touch it. Either way, Walgreens Boots Alliance wins.
A close below $74 could result in another leg lower to the mid-$60s.
What should investors make of private equity firms scaling back some of their prized positions?
Investors watching 13F portfolioS for investment clues are reminded to look at a fund's whole portfolio before following too closely in its footsteps
Jim Cramer says Target's first quarter earnings report 'stung' because he was expecting the retailer to do much better.
Jim Cramer says UnitedHealth's stock is going much higher, and it is a 'terrific' name to own.
UnitedHealth Group is a terrific stock to own and the company proved itself with an impressive earnings report this week, says Jim Cramer.
Jim Cramer says Walgreens is set to move higher if its acquisition of Rite Aid closes or breaks down.
Walgreens' ability to divest itself of assets is crucial to it obtaining regulatory approval in its bid to acquire Rite Aide.
The latest rules are seen likely to prompt a rethink of the $150 billion pharmaceuticals deal.
WBA could continue to work higher, but gains may be hard to achieve.
U.S. stocks dropped on Tuesday morning following weak German manufacturing data for February and a Japanese yen that continues to strengthen.
U.S. futures were down as earnings season starts to heat up.
In 'What's Ahead on Wall Street' for the week of April 4, we've got several key companies we're watching on the earnings front.
TheStreet's Jim Cramer awaits quarterly results from Walgreens Boots Alliance, due Tuesday, and Rite Aid results, due Thursday.
Today's in-line report is relatively inconsequential, near-term.
You may have lost by staying away, but not as much as if you had bought the stock.
The mounting rhetoric from the Democratic presidential candidate's camp may have more clout on Wall Street than you think.